Us Bancorp \De\ Aptevo Therapeutics Inc. Transaction History

Us Bancorp \De\

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$6.21 - $48.36 $68 - $531	-11 Reduced 91.67%	1 $0
Q2 2020 Aug 07, 2020	SELL	$3.11 - $9.27 $9 - $27	-3 Reduced 20.0%	12 $0
Q1 2020 May 13, 2020	BUY	$3.29 - $9.73 $49 - $145	15 New	15 $0

Ticker APVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,090,640
Market Cap $22.4M
Description
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.